Compositions of specific binding agents to hepatocyte growth factor

Details for Australian Patent Application No. 2008269086 (hide)

Owner Amgen Inc.

Inventors Rajan, Rahul; Aoki, Mariko; Li, Tiansheng; Chu, Grace; Nagapudi, Karthik; Huang, Zhouhong; Lueras, Alexis

Agent Shelston IP

Pub. Number AU-A-2008269086

PCT Pub. Number WO2009/002521

Priority 60/937,283 25.06.07 US

Filing date 25 June 2008

Wipo publication date 31 December 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/002521 Priority application(s): WO2009/002521

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008269094-Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents

2008269081-Influenza inhibiting compositions and methods